In patients with persistent atrial fibrillation (AF), electrical cardioversion is very effective in restoring sinus rhythm if modern, biphasic cardioverters are used. However, approximately 50 per cent of the successfully cardioverted patients experience a recurrence of AF within a few weeks. Therefore, valid predictors for AF recurrence would be of great clinical relevance, to avoid unnecessary procedures. In the PRE-ELECTRIC study, we will investigate the predictive value of potential new biomarkers with respect to AF recurrence within 30 days after electrical cardioversion. We will investigate serum and plasma biomarkers, electrocardiological markers and echocardiographic variables in this respect. The study will be undertaken as a prospective cohort study at Bærum Hospital, Vestre Viken Hospital Trust, with national and international collaborators.
Study Type
OBSERVATIONAL
Enrollment
270
Bærum Hospital, Vestre Viken
Sandvika, Bærum, Norway
Atrial fibrillation recurrence
ECG-documented atrial fibrillation recurrence after successful cardioversion
Time frame: 30 days after electrical cardioversion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.